Literature DB >> 2965729

Trypanosoma cruzi-induced suppression of IL-2 production. I. Evidence for the presence of IL-2-producing cells.

R L Tarleton1.   

Abstract

Mice infected with the protozoan parasite Trypanosoma cruzi, the causative agent of human Chagas' disease, are profoundly immunodepressed in their response to various Ag and mitogens. A key factor in this immunosuppression is the essential inability to produce the T cell growth factor IL-2. In this study we demonstrate that this failure to produce IL-2 in response to mitogen stimulation is not the result of the absence of production of soluble or membrane-bound IL-1 by macrophages. Limiting dilution analysis of the precursor frequency of IL-2 producers suggests that an adequate number of precursors for IL-2 production are present in the spleens of infected mice, but that their activity may be regulated by suppressor cells. The presence of precursor cells for IL-2 production is supported by experiments showing that the combination of calcium ionophores and PMA elicits IL-2 production by spleen cells from both normal and T. cruzi-infected mice. Although Con A can provide either of the signals necessary for IL-2 production, calcium flux or protein kinase C activation, to T cells from normal mice, Con A in combination with either calcium ionophore or phorbol ester failed to activate T cells from infected mice to produce IL-2. Preculture of spleen cells from infected mice for 48 to 72 h before addition of Con A results in near normal production of IL-2. This recovery of the capacity to produce IL-2 does not occur if parasite Ag is present during the preculture period. These results suggest that the inability of T cells from T. cruzi-infected mice to produce IL-2 in vitro in response to Con A is not due to the lack of IL-2-producing cells, but may be the result of the maturational state of the T cells or to the presence of a suppressor population.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2965729

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  17 in total

1.  Peptide-based analysis of the amino acid sequence important to the immunoregulatory function of Trypanosoma cruzi Tc52 virulence factor.

Authors:  Margarida Borges; Anabela Cordeiro Da Silva; Denis Sereno; Ali Ouaissi
Journal:  Immunology       Date:  2003-05       Impact factor: 7.397

2.  Trypanosoma cruzi-induced suppression of human peripheral blood lymphocytes activated via the alternative (CD2) pathway.

Authors:  L A Beltz; F Kierszenbaum; M B Sztein
Journal:  Infect Immun       Date:  1990-04       Impact factor: 3.441

3.  CD4+ CD25+ Foxp3- T-regulatory cells produce both gamma interferon and interleukin-10 during acute severe murine spotted fever rickettsiosis.

Authors:  Rong Fang; Nahed Ismail; Thomas Shelite; David H Walker
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

4.  Infection with Trypanosoma cruzi selectively upregulates B7-2 molecules on macrophages and enhances their costimulatory activity.

Authors:  S Frosch; D Küntzlin; B Fleischer
Journal:  Infect Immun       Date:  1997-03       Impact factor: 3.441

5.  Benznidazole, a drug employed in the treatment of Chagas' disease, down-regulates the synthesis of nitrite and cytokines by murine stimulated macrophages.

Authors:  S Revelli; C Le Page; E Piaggio; J Wietzerbin; O Bottasso
Journal:  Clin Exp Immunol       Date:  1999-11       Impact factor: 4.330

6.  Lack of effect of mouse adenovirus type 1 infection on cell surface expression of major histocompatibility complex class I antigens.

Authors:  S C Kring; K R Spindler
Journal:  J Virol       Date:  1996-08       Impact factor: 5.103

7.  Role of excretory-secretory metabolites of Fasciola gigantica in modulating delayed-type hypersensitivity in rats.

Authors:  G Ganga; J P Varshney; R L Sharma
Journal:  Vet Res Commun       Date:  2004-07       Impact factor: 2.459

Review 8.  Chagas' disease.

Authors:  H B Tanowitz; L V Kirchhoff; D Simon; S A Morris; L M Weiss; M Wittner
Journal:  Clin Microbiol Rev       Date:  1992-10       Impact factor: 26.132

9.  Impairment of monocytic function during Trypanosoma cruzi infection.

Authors:  M J Louie; W R Cuna; C Rodriguez De Cuna; L Mayer; K Sperber
Journal:  Clin Diagn Lab Immunol       Date:  1994-11

10.  Does interleukin-2 restore lymphocyte responses suppressed by Trypanosoma cruzi?

Authors:  F Kierszenbaum; H Mejia Lopez; M B Sztein
Journal:  Immunology       Date:  1993-11       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.